Actively Recruiting

Age: 18Years +
All Genders
ID06800430

Vein Graft Failure and Cardiovascular Consequences of Coronary Artery Bypass Graft Surgery

Led by University of Edinburgh · Updated on 2026-04-20

70

Participants Needed

1

Research Sites

18 weeks

Total Duration

On this page

Sponsors

U

University of Edinburgh

Lead Sponsor

N

NHS Lothian

Collaborating Sponsor

AI-Summary

What this Trial Is About

Researchers are investigating the causes and effects of saphenous vein graft failure following coronary artery bypass graft (CABG) surgery. This observational cohort study focuses on understanding inflammation, thrombosis, and fibrosis in vein grafts after surgery. It includes two groups: patients recently undergoing CABG with at least one vein graft and patients with prior CABG (at least 5 years ago) who show symptoms suggesting vein graft failure. The study aims to provide insight into complications like heart attacks and strokes after CABG surgery. Participants will undergo advanced imaging using total-body positron emission tomography and computed tomography (PET-CT) combined with coronary computed tomography angiography to observe the vein grafts, heart, brain, and other body areas. The first group will be scanned within 28 days of their surgery and again after 12 months, while the second group will have imaging prior to their clinical invasive coronary angiography. Additional assessments include an echocardiogram and blood tests, with blood samples taken for immediate and future analysis. The study will enroll up to 150 participants and last for 36 months. During this time, participants will have clinical reviews, imaging scans, blood sampling, and follow-up visits. Researchers will measure platelet, fibroblast, and macrophage activation over three years, along with systemic cardiovascular disease. The study's goal is to better understand vein graft failure and its cardiovascular consequences after CABG surgery.

CONDITIONS

Brief Title

Graft Failure and Consequences of Coronary Artery Bypass Graft Surgery

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Adults 18 years of age or older
  • Patients undergoing CABG surgery for multivessel coronary artery disease with at least one saphenous vein graft
  • Patients who had CABG surgery 5 or more years ago for multivessel disease with two or more saphenous vein grafts
  • Patients referred for invasive coronary angiography due to symptoms and suspected graft vasculopathy
Not Eligible

You will not qualify if you...

  • Patients with a life expectancy less than 2 years
  • Patients with severe kidney failure (estimated glomerular filtration rate less than 30 mL/min/1.73 m2)
  • Patients on immunosuppressive therapies
  • Pregnant or breastfeeding females of child-bearing age
  • Known allergy or contraindication to iodinated contrast or radiotracer
  • Patients unable to tolerate lying flat (supine position)
  • Patients unable to provide informed consent

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Diagnostic Evaluation

Duration - Within 28 days before or after coronary artery bypass graft (CABG) surgery for Cohort 1, or prior to invasive coronary angiography for Cohort 2

Participants undergo clinical review including blood sampling, transthoracic echocardiogram, total-body positron emission tomography computed tomography (PET-CT) imaging, and CT coronary angiography to assess graft status.

1 to 2 visits depending on cohort

Long-term Monitoring

Duration - 12 months

Participants are followed over time with repeat imaging and clinical assessments to monitor inflammation, thrombosis, fibrosis, and graft function.

1 follow-up visit at 12 months

Trial Site Locations

Total: 1 location

1

Royal Infirmary of Edinburgh

Edinburgh, Midlothian, United Kingdom, EH16 4SA

Actively Recruiting

Loading map...

Research Team

L

Laura E Clark, BSc, MBChB, MRCS(Ed)

D

David E Newby, BSc (Hons) PhD BM DM DSc FRCP

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

2

Similar Trials

A Single Centre Study Comparing Continuous Interstitial Flui...

Coronary Artery Bypass

Actively Recruiting

1 location

Allogeneic Hematopoietic Stem Cell Transplant for Patients W...

Graft Failure

Actively Recruiting

1 location

CABGpreHAB- Home-based Multimodal Prehabilitation for Electi...

Ischaemic Heart Disease

Actively Recruiting

1 location

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here